SCHEMBL1727434

SCHEMBL1727434

Cc1ccc(S(=O)(=O)O)c(CCO)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.38
HSD17B10 Q99714 2/20 0.38
AMY1A P0DUB6 1/20 0.37
RECQL P46063 3/20 0.36
POLB P06746 2/20 0.36
MEP1B Q16820 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
CASP6 P55212 1/20 0.36
ELAVL1 Q15717 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
MYC P01106 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
MPL P40238 1/20 0.34
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8472148 0.97 GAA (0.37) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL1180196 0.91 GAA (0.41) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL30823619 0.91 GAA (0.41) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL15311994 0.90 CA2 (0.39) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL8470871 0.88 CA2 (0.36) GAAHSD17B10AMY1ARECQLPOLB
Pyridine SCHEMBL2549494 0.88 HSD17B10 (0.38) GAAHSD17B10RECQLPOLBALDH1A1
SCHEMBL30723203 0.87 GAA (0.39) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL5718625 0.87 GAA (0.39) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL29975298 0.87 GAA (0.39) GAAHSD17B10AMY1ARECQLPOLB
SCHEMBL816601 0.87 GAA (0.39) GAAHSD17B10AMY1ARECQLPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110204543-B Pyrrolopyridinone bifunctional molecular compound based on Cereblon ligand induced BET degradation 江苏省中医药研究院 2022-03-29 CN disclosed
CN-110143961-B Pyrrolo-pyridone bifunctional molecular compound based on VHL ligand-induced BET degradation 江苏省中医药研究院 2022-03-29 CN disclosed
EP-2940007-B1 TYROSINE DERIVATIVE AND MANUFACTURING METHOD FOR TYROSINE DERIVATIVE NARD INSTITUTE LTD (JP) 2017-12-20 EP disclosed
EP-2940007-A2 TYROSINE DERIVATIVE AND MANUFACTURING METHOD FOR TYROSINE DERIVATIVE Nard Institute, Ltd. (JP) 2015-11-04 EP disclosed
US-8907126-B2 Tyrosine derivative and method for producing tyrosine derivative NARD INSTITUTE, LTD. (JP) 2014-12-09 US disclosed
US-20140187814-A1 TYROSINE DERIVATIVE AND METHOD FOR PRODUCING TYROSINE DERIVATIVE NARD INSTITUTE, LTD. (JP) 2014-07-03 US disclosed
US-8506930-B2 Compounds having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2013-08-13 US disclosed
US-8404036-B2 Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-03-26 US disclosed
US-8303935-B2 Alkoxy substituted imidazo[1,2-a]pyridines having affinity for amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-11-06 US disclosed
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2012-10-25 US disclosed
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-05-26 US disclosed
US-20100267952-A1 USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME NIHON MEDI-PHYSICS CO., LTD. (JP) 2010-10-21 US disclosed
EP-2218463-A1 USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME Nihon Medi-Physics Co., Ltd. (JP) 2010-08-18 EP disclosed
US-20090252679-A1 Novel Compound Having Affinity for Amyloid NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-10-08 US disclosed
EP-2019103-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID NIHON MEDI-PHYSICS CO., LTD. (JP) 2009-01-28 EP disclosed
CN-101103002-A 3,4,(5)-substituted tetrahydropyridines NOVARTIS AG (CH) 2008-01-09 CN disclosed
CN-1250549-C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands HOFFMANN LA ROCHE (CH) 2006-04-12 CN disclosed
CN-1483034-A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands - 2004-03-17 CN disclosed
EP-0682535-A1 NEW MATERIALS BIOCOMPATIBLES LIMITED (GB) 1995-11-22 EP disclosed
WO-1994016748-A1 NEW MATERIALS BIOCOMPATIBLES LIMITED (GB) 1994-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187814-A1 TYROSINE DERIVATIVE AND METHOD FOR PRODUCING TYROSINE DERIVATIVE TH, MTNR1A, MTNR1B GAA 4437/4885HSD17B10 2160/4885AMY1A 4228/4885
US-20110123784-A1 WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME IK, RB1, COL1A1 GAA 2451/4885HSD17B10 2848/4885AMY1A 345/4885
US-20090252679-A1 Novel Compound Having Affinity for Amyloid APBA1, SAAL1, SLC43A1 GAA 1744/4885HSD17B10 3826/4885AMY1A 13/4885
US-20100267952-A1 USE OF NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID, AND PROCESS FOR PRODUCTION OF THE SAME APBA1, APP, SAAL1 GAA 3005/4885HSD17B10 3437/4885AMY1A 4/4885
US-20120271053-A1 NOVEL COMPOUND HAVING AFFINITY FOR AMYLOID APBA1, SAAL1, SLC43A1 GAA 1744/4885HSD17B10 3826/4885AMY1A 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.